CARDRASE Drug Patent Profile
✉ Email this page to a colleague
When do Cardrase patents expire, and when can generic versions of Cardrase launch?
Cardrase is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in CARDRASE is ethoxzolamide. Additional details are available on the ethoxzolamide profile page.
Summary for CARDRASE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Patent Applications: | 1,382 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CARDRASE at DailyMed |
US Patents and Regulatory Information for CARDRASE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | CARDRASE | ethoxzolamide | TABLET;ORAL | 011047-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pharmacia And Upjohn | CARDRASE | ethoxzolamide | TABLET;ORAL | 011047-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
